Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
SUMMARY
The
long-term
effects
of
repeated
COVID-19
vaccinations
on
adaptive
immunity
remain
incompletely
understood.
Here,
we
conducted
a
comprehensive
three-year
longitudinal
study
examining
T
cell
and
antibody
responses
in
78
vaccinated
individuals
without
reported
symptomatic
infections.
We
observed
distinct
dynamics
Spike-specific
humoral
cellular
immune
across
multiple
vaccine
doses.
While
titers
incrementally
increased
stabilized
with
each
booster,
rapidly
plateaued,
maintaining
remarkable
stability
CD4+
CD8+
subsets.
Notably,
approximately
30%
participants
showed
reactivity
to
non-Spike
antigens,
consistent
asymptomatic
Single-cell
RNA
sequencing
revealed
diverse
landscape
phenotypes,
no
evidence
exhaustion
or
significant
functional
impairment.
However,
qualitative
changes
were
infection,
exhibiting
unique
immunological
characteristics,
including
frequencies
Th17-like
cells
GZMKhi/IFNR
Remarkably,
this
group
associated
progressive
increase
regulatory
cells,
potentially
indicating
balanced
response
that
may
mitigate
immunopathology.
By
regularly
stimulating
memory,
boosters
contribute
stable
enhanced
response,
which
provide
better
protection
against
Язык: Английский
Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination
Journal of Virology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
ABSTRACT
The
COVID-19
pandemic
has
greatly
enhanced
our
understanding
of
CD8+
T
cell
immunity
and
their
role
in
natural
infection
vaccine-induced
protection.
Rapid
early
SARS-CoV-2-specific
responses
have
been
associated
with
efficient
viral
clearance
mild
disease.
Virus-specific
can
compensate
for
waning,
morbidity-related,
iatrogenic
reduction
humoral
immunity.
After
or
vaccination,
memory
cells
are
formed,
which
mount
an
recall
response
the
event
breakthrough
help
to
protect
from
severe
Due
breadth
ability
target
mainly
highly
conserved
epitopes,
also
able
cross-recognize
epitopes
variants,
thus
maintaining
even
after
emergence
evolution.
In
some
cases,
however,
may
contribute
pathogenesis
COVID-19.
particular,
delayed
uncontrolled,
e.g.,
nonspecific
hyperactivated,
cytotoxic
linked
poor
outcomes.
this
minireview,
we
summarize
tremendous
knowledge
about
SARS-CoV-2
vaccination
that
gained
over
past
5
years,
while
highlighting
critical
gaps
remain.
Язык: Английский
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study
EBioMedicine,
Год журнала:
2024,
Номер
105, С. 105203 - 105203
Опубликована: Июнь 18, 2024
Hybrid
immunity
to
SARS-CoV-2,
resulting
from
both
vaccination
and
natural
infection,
remains
insufficiently
understood
in
paediatric
populations,
despite
increasing
rates
of
breakthrough
infections
among
vaccinated
children.
Язык: Английский
Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history
Communications Medicine,
Год журнала:
2025,
Номер
5(1)
Опубликована: Май 15, 2025
Abstract
Background
High
spike-based
vaccine
coverage
led
to
a
high
seroprevalence
of
anti-spike
(S)
antibodies
against
SARS-CoV-2
in
Japanese
adults
2024.
Nevertheless,
the
COVID-19
epidemic
continues,
and
individuals
with
hybrid
immunity
are
becoming
more
common
these
populations.
Methods
We
conducted
prospective
cohort
study
measure
serum
anti-SARS-CoV-2
antibody
levels
4496
as
part
national
seroepidemiological
survey.
This
evaluated
correlation
between
first-visit
their
effectiveness
providing
protection
until
second
visit
during
Omicron
BA.5
epidemic.
Results
Reduced
symptomatic
infection
risk
was
found
be
associated
anti-S
antibody,
anti-nucleocapsid
(N)
neutralizing
levels.
However,
reduced
asymptomatic
or
limited.
In
contrast,
higher
anti-N
were
strongly
linked
risk.
Furthermore,
also
re-infection
immunity.
Conclusion
These
observations
highlight
potential
level
correlate
re-infection.
The
findings
indicate
that
have
distinct
protective
both
beyond
circulating
viral
strains,
which
antibodies.
Язык: Английский
Ethnic Comparisons of Spike-Specific CD4+ T Cells, Serological Responses, and Neutralizing Antibody Titers Against SARS-CoV-2 Variants
Vaccines,
Год журнала:
2025,
Номер
13(6), С. 607 - 607
Опубликована: Июнь 4, 2025
Background/Objectives:
To
evaluate
how
immune
responses
compare
among
ethnic
groups
approximately
2
years
after
receiving
a
third
dose
of
COVID-19
vaccine
(BNT162b2,
mRNA-1273,
ChAdOx1or
BBIBP-CorV),
we
tested
T
cell
and
Spike-specific
RBD-antibody
titer,
neutralized
antibody
titer
levels
utilizing
Spectral
Flow
cytometry,
ELISA,
SARS-CoV-2
pseudotyped-based
neutralization
assays,
respectively.
Methods:
Forty-four
individuals
from
January–December
2023
were
identified
within
the
cohort
classified
into
different
backgrounds;
Black
(N
=
13),
Asian
14),
Caucasian
17).
We
recognize
that
“Asian”
group
includes
diverse
subpopulations
with
distinct
genetic
environmental
backgrounds,
which
could
not
be
further
stratified
due
to
sample-size
limitations.
AIM+,
CD4+,
CD8+
assessed
evaluated
against
variants,
including
ancestral
Wuhan,
Delta,
multiple
Omicron
subvariants
(B1.1529,
BA2.86,
BA.4/5,
XBB.1).
Alongside
RBD-IgG
neutralizing
titers
Wuhan.
Spearman’s
correlation
analysis
was
utilized
determine
corelative
relationships
AIM+
CD4+
responses,
as
well
titers.
Results:
Our
results
show
robust
comparable
across
all
groups,
significant
positive
between
these
two
measurements.
Significant
differences
observed
in
T-cell
activation,
participants
exhibiting
lower
frequencies
cells
higher
cytokine-producing
(TNF-α,
IFN-γ,
IL-2)
compared
group.
Breakthrough
infection
status
fully
controlled
may
influence
findings.
Conclusion:
Despite
small
sample
size
potential
confounding
by
natural
infections
our
long-time-span
sampling,
data
suggest
persistent
cellular
humoral
immunity
vaccination
ethnicities,
notable
activation
cytokine
profile.
These
preliminary
observations
highlight
need
for
larger,
more
detailed
studies
consider
intra-ethnic
diversity
hybrid
better
understand
responses.
Язык: Английский
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Дек. 9, 2024
Age-associated
differences
in
the
effect
of
repetitive
vaccination,
particularly
on
memory
T-cell
and
B-cell
responses,
remain
unclear.
While
older
adults
(aged
≥65
years)
exhibited
enhanced
IgG
responses
following
COVID-19
mRNA
booster
they
produced
fewer
spike-specific
circulating
follicular
helper
T
cells-1
than
younger
adults.
Similarly,
cytotoxic
CD8
Язык: Английский